Clinical trials

  • RO7790121 for Rheumatoid arthritis (moderate to severe)
  • 64Cu-DOTA-AE105 for Glioblastoma
  • ROPINIROLE for Healthy volunteers
  • Monobenzon for Malignant melanoma | Advanced or metastatic melanoma
  • VENT-03 for Cutaneous lupus erythematosus
  • SACITUZUMAB TIRUMOTECAN for Urothelial carcinoma | Bladder cancer
  • empagliflozin for Cardiac surgery-associated acute kidney injury|Acute kidney injury
  • ALKS 2680 for Narcolepsy Type 1 | Narcolepsy Type 2 | Idiopathic hypersomnia
  • FLORTAUCIPIR (18F) for Alzheimer's disease|Alzheimer's pathology
  • RINATABART SESUTECAN for Endometrial cancer | Recurrent endometrial cancer | Metastatic endometrial cancer
  • Xanomeline tartrate for Agitation associated with Alzheimer's disease | Alzheimer's disease
  • ATEZOLIZUMAB for deficient mismatch repair (dMMR) colorectal cancer|Follicular lymphoma|Chronic lymphocytic leukemia|Pleural mesothelioma|Melanoma|Small cell lung carcinoma|AL amyloidosis|Hepatocellular carcinoma|Hodgkin lymphoma|Cholangiocarcinoma|Locally advanced cutaneous squamous cell carcinoma|Non-small cell lung carcinoma|deficient mismatch repair (dMMR) colorectal adenocarcinoma|Esophageal squamous cell carcinoma|Gastric cardia cancer|Myeloma